INSIDERFilingvia Quantisnow
Alimera Sciences Inc. logo

Alimera Sciences (ALIM) executive Jones received 372 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

John Philip Jones (executive at Alimera Sciences Inc., ALIM) reported that they received 372 shares on Oct 31, 2022. After these transactions the filing shows 32,185 shares held directly.

Reporting person
Jones John Philip
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Oct 31, 2022Grant or award (A)Common Stock1+372$4.44$1,65132,185 direct

Holdings before and after

  • Common Stock: 31,813 to 32,185 direct

Footnotes from the filing

  1. 1. These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Jones report in this ALIM Form 4?

John Philip Jones (executive at Alimera Sciences Inc., ALIM) reported that they received 372 shares on Oct 31, 2022. After these transactions the filing shows 32,185 shares held directly.

How many ALIM shares does Jones hold after this filing?

The filing shows 32,185 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for ALIM

Earlier insider filings at ALIM

Quantisnow market dataNASDAQ
Alimera Sciences Inc. logo
ALIM
Alimera Sciences Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2010
Get push alerts for ALIM

Follow ALIM and get a push notification the moment its next story breaks.

Full ALIM profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALIM (Alimera Sciences Inc.) and more on Quantisnow.